acetaminophen 300 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule
- RxCUI
- 1431286
- RxNorm name
- acetaminophen 300 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule
- Display name
- Acetaminophen/Butalbital/Caffeine/Codeine (Oral Pill)
- Full name
- acetaminophen 300 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule
- Term type
- SCD
- Status
- Active
- Strength
- 300-50-40-30 mg
- Dose form
- Cap
- Route
- Oral Pill
- Updated
- 2026-10-17 23:55:42
RxNorm Status History#
- Status
- Active
- Source
- RXNORM
- Current
- YES
- Release start
- 082013
- Active start
- 082013
- Multiple ingredient
- YES
- Branded
- NO
Ingredients And Strength#
| Ingredient | Strength | Base | Basis of strength |
|---|---|---|---|
| acetaminophen | 300 MG / 1 EACH | acetaminophen | acetaminophen |
| caffeine | 40 MG / 1 EACH | caffeine | caffeine |
| butalbital | 50 MG / 1 EACH | butalbital | butalbital |
| codeine phosphate | 30 MG / 1 EACH | codeine | codeine phosphate |
Dose Form Concepts#
| Dose form | RxCUI |
|---|---|
| Oral Capsule | 316965 |
Derived Ingredient Concepts#
| Ingredient | RxCUI |
|---|---|
| acetaminophen | 161 |
| caffeine | 1886 |
| butalbital | 19860 |
| codeine | 2670 |
Source Vocabulary Codes#
| Code type | Values | Count | Category |
|---|---|---|---|
| PRESCRIBABLE | Y | 1 | ATTRIBUTES |
| RXNAV_STR | acetaminophen 300 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule | 1 | NAMES |
| RxNorm Name | acetaminophen 300 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule | 1 | NAMES |
| RxNorm Synonym | APAP 300 MG / butalbital 50 MG / Caffeine 40 MG / Codeine Phosphate 30 MG Oral Capsule | 1 | NAMES |
| TTY | SCD | 1 | ATTRIBUTES |
| SPL_SET_ID | 2 | CODES | |
| RxCUI | 1431286 | 1 | CODES |
| MMSL_CODE | 2 | CODES |
FDA NDC Products And Packages#
| Package NDC | Product NDC | Name | Labeler | Application |
|---|---|---|---|---|
| 0054-0650-25 | 0054-0650 | Butalbital, Acetaminophen, Caffeine and Codeine Phosphate Butalbital, Acetaminophen, Caffeine and Codeine Phosphate | Hikma Pharmaceuticals USA Inc. | ANDA215138 |
| 0591-2641-01 | 0591-2641 | Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate | Actavis Pharma, Inc. | ANDA076560 |
Drugs@FDA Applications#
| Application | NDC | Name | Marketing category | Labeler |
|---|---|---|---|---|
| ANDA215138 | 0054-0650 | Butalbital, Acetaminophen, Caffeine and Codeine Phosphate Butalbital, Acetaminophen, Caffeine and Codeine Phosphate | ANDA | Hikma Pharmaceuticals USA Inc. |
| ANDA076560 | 0591-2641 | Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate | ANDA | Actavis Pharma, Inc. |
UNII Substances#
No records found.
openFDA label cross-check#
OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.
| Brand | Generic | Manufacturer | SPL set ID | Effective date | Available safety fields | Join |
|---|---|---|---|---|---|---|
| Butalbital, Acetaminophen, Caffeine and Codeine Phosphate | BUTALBITAL, ACETAMINOPHEN, CAFFEINE AND CODEINE PHOSPHATE | Hikma Pharmaceuticals USA Inc. | 6e0e8abc-512b-42f7-8323-434c589edecf | 2026-01-02 | Boxed warning, Warnings, Adverse reactions | 0054-0650-25 0054-0650 00054065025 1431286 |
| Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate | BUTALBITAL, ACETAMINOPHEN, CAFFEINE, AND CODEINE PHOSPHATE | Actavis Pharma, Inc. | 52321fe5-c001-4e2d-8149-3197ddc13764 | 2025-12-10 | Boxed warning, Warnings, Adverse reactions | 0591-2641-01 0591-2641 00591264101 1431286 |
Reported adverse events (FAERS/openFDA)#
Adverse event summaries are temporarily unavailable. Other product information remains available.
DailyMed RxNorm Mappings#
| Set ID | RxNorm mappings | Terms | SPL version | Label | Effective |
|---|---|---|---|---|---|
| df9801fc-03fe-41da-a6b3-0f76788217c9 | butalbital 50 MG / acetaminophen 300 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [PSN] · acetaminophen 300 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [SCD] · APAP 300 MG / butalbital 50 MG / Caffeine 40 MG / Codeine Phosphate 30 MG Oral Capsule [SY] | 3 | 11 | These highlights do not include all the information needed to use FIORICET with CODEINE safely and effectively. See full prescribing information for FIORICET with CODEINE. FIORICET ® with CODEINE (butalbital, acetaminophen, caffeine, and codeine phosphate) Capsules, for oral use, CIII Initial U.S. Approval: 1992 | 20210301 |
| 8f8c5c01-5859-4843-adf4-8116ddaedc90 | butalbital 50 MG / acetaminophen 300 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [PSN] · acetaminophen 300 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [SCD] · APAP 300 MG / butalbital 50 MG / Caffeine 40 MG / Codeine Phosphate 30 MG Oral Capsule [SY] | 3 | 11 | These highlights do not include all the information needed to use Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules safely and effectively. See full prescribing information for Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules for oral use, CIII. Initial U.S. Approval: 1992 | 20200221 |
| 52321fe5-c001-4e2d-8149-3197ddc13764 | butalbital 50 MG / acetaminophen 300 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [PSN] · acetaminophen 300 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [SCD] · APAP 300 MG / butalbital 50 MG / Caffeine 40 MG / Codeine Phosphate 30 MG Oral Capsule [SY] | 3 | 10 | These highlights do not include all the information needed to use Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules safely and effectively. See full prescribing information for Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules. Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules for oral use, CIII Initial U.S. Approval: 1992 | 20251210 |
| 6e0e8abc-512b-42f7-8323-434c589edecf | butalbital 50 MG / acetaminophen 300 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [PSN] · acetaminophen 300 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [SCD] · APAP 300 MG / butalbital 50 MG / Caffeine 40 MG / Codeine Phosphate 30 MG Oral Capsule [SY] | 3 | 6 | These highlights do not include all the information needed to use BUTALBITAL, ACETAMINOPHEN, CAFFEINE, AND CODEINE PHOSPHATE CAPSULES safely and effectively. See full prescribing information for BUTALBITAL, ACETAMINOPHEN, CAFFEINE, AND CODEINE PHOSPHATE CAPSULES. BUTALBITAL, ACETAMINOPHEN, CAFFEINE, AND CODEINE PHOSPHATE capsules, for oral use, CIII Initial U.S. Approval: 1992 | 20260102 |
| b96c0356-39e3-496a-a622-603f8a91f49e | butalbital 50 MG / acetaminophen 300 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [PSN] · acetaminophen 300 MG / butalbital 50 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule [SCD] · APAP 300 MG / butalbital 50 MG / Caffeine 40 MG / Codeine Phosphate 30 MG Oral Capsule [SY] | 3 | 2 | These highlights do not include all the information needed to use Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules safely and effectively. See full prescribing information for Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules for oral use, CIII. Initial U.S. Approval: 1992 | 20210614 |
Recently Linked DailyMed Labels#
| Set ID | Title | Manufacturer | Effective |
|---|---|---|---|
| 6e0e8abc-512b-42f7-8323-434c589edecf | These highlights do not include all the information needed to use BUTALBITAL, ACETAMINOPHEN, CAFFEINE, AND CODEINE PHOSPHATE CAPSULES safely and effectively. See full prescribing information for BUTALBITAL, ACETAMINOPHEN, CAFFEINE, AND CODEINE PHOSPHATE CAPSULES. BUTALBITAL, ACETAMINOPHEN, CAFFEINE, AND CODEINE PHOSPHATE capsules, for oral use, CIII Initial U.S. Approval: 1992 | Hikma Pharmaceuticals USA Inc. | West-Ward Columbus Inc. | 20260102 |
| 52321fe5-c001-4e2d-8149-3197ddc13764 | These highlights do not include all the information needed to use Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules safely and effectively. See full prescribing information for Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules. Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules for oral use, CIII Initial U.S. Approval: 1992 | Actavis Pharma, Inc. | 20251210 |
| b96c0356-39e3-496a-a622-603f8a91f49e | These highlights do not include all the information needed to use Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules safely and effectively. See full prescribing information for Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules for oral use, CIII. Initial U.S. Approval: 1992 | LGM Pharma Solutions, LLC | 20210614 |
| 8f8c5c01-5859-4843-adf4-8116ddaedc90 | These highlights do not include all the information needed to use Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules safely and effectively. See full prescribing information for Butalbital, Acetaminophen, Caffeine, and Codeine Phosphate Capsules for oral use, CIII. Initial U.S. Approval: 1992 | Nexgen Pharma, Inc. | 20200221 |
Drug Classes#
| Source | Class ID | Class | Type | Relationship | Drug concept |
|---|---|---|---|---|---|
| ATC | N02BE | Anilides | ATC1-4 | acetaminophen | |
| ATC | R05DA | Opium alkaloids and derivatives | ATC1-4 | codeine | |
| ATC | D11AX | Other dermatologicals | ATC1-4 | caffeine | |
| ATC | N06BC | Xanthine derivatives | ATC1-4 | caffeine | |
| FDASPL | D001463 | Barbiturates | CHEM | has_chemical_structure | butalbital |
| FDASPL | D014970 | Xanthines | CHEM | has_chemical_structure | caffeine |
| FDASPL | N0000175693 | Barbiturate | EPC | has_epc | butalbital |
| FDASPL | N0000175739 | Central Nervous System Stimulant | EPC | has_epc | caffeine |
| FDASPL | N0000175790 | Methylxanthine | EPC | has_epc | caffeine |
| FDASPL | N0000175729 | Central Nervous System Stimulation | PE | has_pe | caffeine |
| MEDRT | D000082 | Acetaminophen | CHEM | has_ingredient | acetaminophen |
| MEDRT | D001463 | Barbiturates | CHEM | has_ingredient | butalbital |
| MEDRT | D002110 | Caffeine | CHEM | has_ingredient | caffeine |
| MEDRT | D003061 | Codeine | CHEM | has_ingredient | codeine phosphate |
| MEDRT | D003061 | Codeine | CHEM | has_ingredient | codeine |
| MEDRT | D009020 | Morphine | CHEM | has_active_metabolites | codeine phosphate |
| MEDRT | D009020 | Morphine | CHEM | has_active_metabolites | codeine |
| MEDRT | D001049 | Apnea | DISEASE | may_treat | caffeine |
| MEDRT | D001249 | Asthma | DISEASE | ci_with | codeine |
| MEDRT | D001249 | Asthma | DISEASE | ci_with | codeine phosphate |
| MEDRT | D003371 | Cough | DISEASE | may_treat | codeine |
| MEDRT | D003371 | Cough | DISEASE | may_treat | codeine phosphate |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | acetaminophen |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | butalbital |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | codeine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | caffeine |
| MEDRT | D004342 | Drug Hypersensitivity | DISEASE | ci_with | codeine phosphate |
| MEDRT | D005221 | Fatigue | DISEASE | may_treat | caffeine |
| MEDRT | D005334 | Fever | DISEASE | may_prevent | acetaminophen |
| MEDRT | D005334 | Fever | DISEASE | may_treat | acetaminophen |
| MEDRT | D005955 | Glucosephosphate Dehydrogenase Deficiency | DISEASE | ci_with | acetaminophen |
| MEDRT | D006261 | Headache | DISEASE | may_treat | butalbital |
| MEDRT | D007415 | Intestinal Obstruction | DISEASE | ci_with | codeine phosphate |
| MEDRT | D007415 | Intestinal Obstruction | DISEASE | ci_with | codeine |
| MEDRT | D008107 | Liver Diseases | DISEASE | ci_with | acetaminophen |
| MEDRT | D010146 | Pain | DISEASE | may_treat | codeine phosphate |
| MEDRT | D010146 | Pain | DISEASE | may_treat | codeine |
| MEDRT | D010146 | Pain | DISEASE | may_treat | acetaminophen |
| MEDRT | D010146 | Pain | DISEASE | may_prevent | acetaminophen |
| MEDRT | D011164 | Porphyrias | DISEASE | ci_with | butalbital |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | codeine |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | butalbital |
| MEDRT | D011247 | Pregnancy | DISEASE | ci_with | codeine phosphate |
| MEDRT | D012131 | Respiratory Insufficiency | DISEASE | ci_with | codeine |
| MEDRT | D012131 | Respiratory Insufficiency | DISEASE | ci_with | codeine phosphate |
| MEDRT | N0000000133 | Enzyme Inhibitors | MOA | has_moa | caffeine |
| MEDRT | N0000175684 | Full Opioid Agonists | MOA | has_moa | codeine |
| MEDRT | N0000175684 | Full Opioid Agonists | MOA | has_moa | codeine phosphate |
| MEDRT | N0000000184 | Monoamine Oxidase Inhibitors | MOA | ci_moa | codeine phosphate |
| MEDRT | N0000000184 | Monoamine Oxidase Inhibitors | MOA | ci_moa | codeine |
| MEDRT | N0000000105 | Neurotransmitter Transporter Interactions | MOA | has_moa | butalbital |
| MEDRT | N0000000108 | Prostaglandin Receptor Antagonists | MOA | has_moa | acetaminophen |
| MEDRT | N0000175439 | Analgesia | PE | has_pe | codeine phosphate |
| MEDRT | N0000175439 | Analgesia | PE | has_pe | codeine |
| MEDRT | N0000008322 | Bronchodilation | PE | has_pe | caffeine |
| MEDRT | N0000008331 | Cardiovascular Activity Alteration | PE | has_pe | caffeine |
| MEDRT | N0000175724 | Central Nervous System Activity Alteration | PE | has_pe | acetaminophen |
| MEDRT | N0000008567 | Decreased Collecting Duct Water Permeability | PE | has_pe | caffeine |
| MEDRT | N0000008701 | Decreased Medullary Respiratory Drive | PE | has_pe | codeine |
| MEDRT | N0000008701 | Decreased Medullary Respiratory Drive | PE | has_pe | codeine phosphate |
| MEDRT | N0000008768 | Decreased Organized Electrical Activity | PE | has_pe | codeine |
| MEDRT | N0000008768 | Decreased Organized Electrical Activity | PE | has_pe | codeine phosphate |
| MEDRT | N0000008768 | Decreased Organized Electrical Activity | PE | has_pe | butalbital |
| MEDRT | N0000008836 | Decreased Prostaglandin Production | PE | has_pe | acetaminophen |
| MEDRT | N0000009072 | Hypothalamic Endocrine Activity Alteration | PE | has_pe | acetaminophen |
| MEDRT | N0000009197 | Increased Central Nervous System Organized Electrical Activity | PE | has_pe | caffeine |
| MEDRT | N0000175725 | Peripheral Nervous System Activity Alteration | PE | has_pe | acetaminophen |
| MEDRT | N0000000026 | Hepatic Metabolism | PK | has_pk | acetaminophen |
| MEDRT | N0000000026 | Hepatic Metabolism | PK | site_of_metabolism | codeine phosphate |
| MEDRT | N0000000026 | Hepatic Metabolism | PK | has_pk | codeine phosphate |
| MEDRT | N0000000026 | Hepatic Metabolism | PK | site_of_metabolism | codeine |
| MEDRT | N0000000026 | Hepatic Metabolism | PK | has_pk | codeine |
| MEDRT | N0000000042 | Renal Excretion | PK | has_pk | codeine phosphate |
| MEDRT | N0000000042 | Renal Excretion | PK | has_pk | acetaminophen |
| MEDRT | N0000000042 | Renal Excretion | PK | has_pk | codeine |
Properties#
| Category | Property | Value |
|---|---|---|
| ATTRIBUTES | AVAILABLE_STRENGTH | 300 MG / 50 MG / 40 MG / 30 MG |
| ATTRIBUTES | GENERAL_CARDINALITY | MULTI |
| ATTRIBUTES | HUMAN_DRUG | US |
| ATTRIBUTES | RXNAV_HUMAN_DRUG | US |
| ATTRIBUTES | SCHEDULE | 3 |
| CODES | ANDA | ANDA076560 |
| CODES | ANDA | ANDA215138 |
| CODES | VUID | 4032595 |
| NAMES | Prescribable Synonym | butalbital 50 MG / acetaminophen 300 MG / caffeine 40 MG / codeine phosphate 30 MG Oral Capsule |
| SOURCES | Source | Gold Standard Alchemy |
| SOURCES | Source | Metathesaurus FDA Structured Product Labels |
| SOURCES | Source | Micromedex RED BOOK |
| SOURCES | Source | Multum MediSource Lexicon |
| SOURCES | Source | National Drug Data File Plus Source Vocabulary |
| SOURCES | Source | Veterans Health Administration National Drug File |